ST
REGN icon

Spot Trading’s Regeneron Pharmaceuticals REGN Stock Holding History

Spot Trading’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$858K Buy
+1,919
New +$913K 0.01% 1276
2016
Q4 		– Sell
-542
Closed -$206K – 3100
2016
Q3 		$218K Sell
542
-4,731
-90% -$1.9M ﹤0.01% 2038
2016
Q2 		$1.84M Buy
5,273
+1,429
+37% +$550K 0.03% 744
2016
Q1 		$1.39M Buy
+3,844
New +$1.58M 0.02% 906
2015
Q4 		– Sell
-167
Closed -$90.5K – 3988
2015
Q3 		$78K Buy
167
+3
+2% +$1.61K ﹤0.01% 3140
2015
Q2 		$84K Buy
+164
New +$80K ﹤0.01% 3147
2015
Q1 		– Sell
-60
Closed -$25.4K – 4259
2014
Q4 		$25K Buy
+60
New +$23.6K ﹤0.01% 3564
2014
Q2 		– Sell
-3,855
Closed -$1.14M – 4771
2014
Q1 		$1.16M Buy
+3,855
New +$1.19M 0.01% 1932
2013
Q4 		– Sell
-695
Closed -$200K – 4242
2013
Q3 		$217K Buy
695
+481
+225% +$127K ﹤0.01% 2962
2013
Q2 		$48K Buy
+214
New +$49.8K ﹤0.01% 3671

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Spot Trading's REGN Position: Q3 2017 in Review

Spot Trading opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2017: 1,919 shares worth $858K. The stake represents 0.01% of the portfolio and ranks #1276 among its holdings. This is a return to the name: Spot Trading previously reported a position in REGN as recently as Q3 2016.

Spot Trading first reported a position in REGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.84M in Q2 2016. 606 funds tracked by Wall St. Rank hold REGN as of Q3 2017.

  • Spot Trading held 1,919 shares of Regeneron Pharmaceuticals worth $858K as of Q3 2017.
  • Regeneron Pharmaceuticals was a new Spot Trading position in Q3 2017.
  • Regeneron Pharmaceuticals made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1276 holding.
  • Spot Trading first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
  • Spot Trading's Regeneron Pharmaceuticals position peaked at $1.84M in Q2 2016.
  • 606 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.